Subscribe To
Biogen (biib) to end one of two parkinson's studies on biib122
Biogen BIIB announced that it is discontinuing one of the two studies on its and partner Denali Therape...
June 6, 2023, 11:59 am
Lava (lvtx) up on j&j's (jnj) cancer study candidate selection
LAVA's (LVTX) shares soar as partner J&J (JNJ) selects a lead candidate for development in clinical studies...
June 2, 2023, 12:09 pm
Exness gives scholarships to three university of cape town students
Multi-asset broker Exness extended its Exness Fintech Scholarship program in South Africa to reward academic excellence among students in the fields o...
June 1, 2023, 7:44 am
Ximen mining gears up for engineering studies at kenville gold mine after securing final permits
Ximen Mining Corp (TSX-V:XIM, OTCQB:XXMMF) said it is getting ready to start engineering and technical studies...
May 31, 2023, 9:34 am
Kodiak (kod) advances with tarcocimab amid stiff competition
Kodiak (KOD) focuses on completing ongoing studies on tarcocimab for several retinal indications. Howev...
May 30, 2023, 12:25 pm
2 dividend stocks to buy and hold for the next decade
studies show that investors who buy and hold stocks tend to outperform those who try to time the market...
May 30, 2023, 10:05 am
Eur/usd outlook: violation of psychological 1.07 support signals bearish continuation
Daily studies remain in full bearish setup and maintain downside pressure for attack at 1.0652 (Fibo 76...
May 30, 2023, 7:59 am
Usd/jpy outlook: bulls started to lose traction on strongly overbought studies/weaker dollar
The USDJPY eases from new over six-month high on Monday, as strongly overbought conditions on daily chart prompted traders to start collecting profits...
May 29, 2023, 10:14 am
Eur/usd: larger bears to remain intact while key 1.0800 resistance zone caps recovery
The Euro edges higher in early Monday trading, generating initial bullish signal on formation of reversal pattern on daily chart, after Friday’s Doj...
May 29, 2023, 8:21 am
Micro switch market is set to grow at a cagr of 5.4% leading to a revenue of us$ 9.2 billion by 2031 | get in-depth studies by transparency market research
Micro switch market size is expected to grow at a rapid pace in the near future due to a surge in demand for micro switches in industrial control pane...
May 26, 2023, 10:30 am
Shockwave medical (swav) hits 52-week high: will it continue?
ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies<...
May 24, 2023, 8:57 am
Graphene manufacturing group signs distribution agreements in thailand, singapore, indonesia and south korea
Graphene Manufacturing Group Ltd (TSX-V:GMG, OTC:GMGMF) said it has signed distribution agreements with four separate distributors in Thailand, Singa...
May 24, 2023, 8:11 am
Maps-sponsored global psychedelic survey gathers data for a crucial view into psychedelic use
SAN JOSE, Calif., May 22, 2023 (GLOBE NEWSWIRE) — The Multidisciplinary Association for Psychedelic studies<...
May 22, 2023, 8:21 pm
A strong set of business survey numbers appears to suit ecb’s intentions
With the euro experiencing a rather difficult month and confirming the various seasonality studies, thi...
May 22, 2023, 11:46 am
Reviva pharmaceuticals announces presentation of clinical pharmacology studies data on brilaroxazine at the aspet 2023 annual meeting
Data reinforce brilaroxazine’s differentiated clinical pharmacology and safety profile Brilaroxazine may be co-administered with other drugs metabol...
May 22, 2023, 10:30 am
Usd/jpy outlook: bulls to pause for consolidation before resuming
Daily studies remain in full bullish setup and support the action, with consolidation to ideally stay a...
May 22, 2023, 9:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am
Teva to present data demonstrating uzedy™ (risperidone) extended-release injectable suspension significantly prolonged time to impending relapse for adults with schizophrenia at the american psychiatr
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TE...
May 20, 2023, 11:00 am